NCT02312063View on ClinicalTrials.gov

Dietary Impacts on Glucose-lowering Effects of Sitagliptin in Type 2 Diabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Sitagliptin

DRUG

Glimepiride

Trial Locations (2)

536-0001

Saiseikai Noe Hospital Osaka, Osaka

553-0003

Kansai Electric Power Hospital, Osaka

All Listed Sponsors
collaborator

Saiseikai Noe Hospital Osaka

UNKNOWN

lead

Kansai Electric Power Hospital

OTHER

NCT02312063 - Dietary Impacts on Glucose-lowering Effects of Sitagliptin in Type 2 Diabetes | Biotech Hunter | Biotech Hunter